Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study

Journal of Urology

Volumn 189, Issue 6, 2013, Pages 2194-2201

  Peters, Kenneth M ^a   Carrico, Donna J ^a   Wooldridge, Leslie S ^b   Miller, Christopher J ^c   MacDiarmid, Scott A ^d  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b MERCY HEALTH PARTNERS   (United States)

^c NAMSA Integra Division   (United States)

^d Alliance Urology Specialists   (United States)

Author keywords

electric stimulation therapy; overactive; tibial nerve; urge; urinary bladder; urinary incontinence

Indexed keywords

ADULT; AGED; APPLICATION SITE BLEEDING; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; NERVE STIMULATION; NERVE STIMULATOR; NEUROMODULATION; OVERACTIVE BLADDER; PATIENT SAFETY; PERCUTANEOUS TIBIAL NERVE STIMULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TIBIAL NERVE; TREATMENT OUTCOME; URGE INCONTINENCE;

AGE FACTORS; AGED; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIBIAL NERVE; TIME FACTORS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE; URODYNAMICS;

EID: 84877616737     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.11.175     Document Type: Article

References (30)

1. P. Ward-Smith The cost of urinary incontinence Urol Nurs 29 2009 188
2. K.S. Coyne, C. Payne, S.K. Bhattacharyya The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey Value Health 7 2004 455
3. D.E. Irwin, I. Milsom, S. Hunskaar Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study Eur Urol 50 2006 1306
4. W.F. Stewart, J.B. Van Rooyen, G.W. Cundiff Prevalence and burden of overactive bladder in the United States World J Urol 20 2003 327
5. S. Tyagi, C.A. Thomas, Y. Hayashi The overactive bladder: epidemiology and morbidity Urol Clin North Am 33 2006 433
6. T.W. Hu, T.H. Wagner Health-related consequences of overactive bladder: an economic perspective BJU Int 96 2005 43
7. P.M. Teleman, J. Lidfeldt, C. Nerbrand Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women BJOG 111 2004 600
8. R.R. Dmochowski, D.K. Newman Impact of overactive bladder on women in the United States: results of a national survey Curr Med Res Opin 23 2007 65
9. C.R. Chapple, V. Khullar, Z. Gabriel The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis Eur Urol 54 2008 543
10. G. Nabi, J.D. Cody, G. Ellis Anticholinergic drugs versus placebo for overactive bladder syndrome in adults Cochrane Database Syst Rev 4 2006 CD003781
11. C.J. Kelleher, L.D. Cardozo, V. Khullar A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance Br J Obstet Gynaecol 104 1997 988
12. M. Lawrence, D.R. Guay, S.R. Benson Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis Pharmacotherapy 20 2000 470
13. C. Hampel Long-term management of overactive bladder with antimuscarinic agents Eur Urol Suppl 6 2007 432
14. R.A. Schmidt, U. Jonas, K.A. Oleson Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group J Urol 162 1999 352
15. E. Finazzi-Agro, F. Petta, F. Sciobica Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial J Urol 184 2010 2001
16. K.M. Peters, D.J. Carrico, R.A. Perez-Marrero Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial J Urol 183 2010 1438
17. K.M. Peters, S.A. MacDiarmid, L.S. Wooldridge Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial J Urol 182 2009 1055
18. S.A. MacDiarmid, K.M. Peters, S.A. Shobeiri Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder J Urol 183 2010 234
19. K.M. Peters, D.J. Carrico, S.A. MacDiarmid Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study Neurourol Urodyn 32 2013 24
20. W. Yoong, P. Shah, R. Dadswell Sustained effectiveness of percutaneous tibial nerve stimulation for overactive bladder syndrome: 2-year follow-up of positive responders Int Urogynecol J 2012 Epub ahead of print
21. C. Burton, A. Sajja, P.M. Latthe Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis Neurourol Urodyn 31 2012 1206
22. A.K. Monga, M.R. Tracey, J. Subbaroyan A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction Int Urogynecol J 23 2012 993
23. L.S. Matza, C.L. Thompson, J. Krasnow Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ) Neurourol Urodyn 24 2005 215
24. J.E. Ware Jr, C.D. Sherbourne The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 30 1992 473
25. K.J. Propert, R.D. Mayer, Y. Wang Responsiveness of symptom scales for interstitial cystitis Urology 67 2006 55
26. E.A. Gormley, D.J. Lightner, K.L. Burgio Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFA Guideline. American Urological Association Education and Research 2012 www.auanet.org/content/media/ OAB-guideline.pdf Accessed November 13, 2012
27. Agency for Healthcare Research and Quality Nonsurgical treatments for urinary incontinence in adult women: diagnosis and comparative effectiveness. U.S. Department of Health and Human Services www.effectivehealthcare.ahrq.gov/ search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid= 1021 Accessed November 13, 2012
28. Food and Drug Administration Guidance for Industry and Food and Drug Administration Staff: Clinical Investigations of Devices Indicated for the Treatment of Urinary Incontinence. U.S. Department of Health and Human Services 2011 www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/ucm070854.pdf Accessed November 13, 2012
29. D.R. Staskin, K.M. Peters, S. MacDiarmid Percutaneous tibial nerve stimulation: a clinically cost effective addition to the overactive bladder algorithm of care Curr Urol Rep 13 2012 327
30. M. Martinson, S. MacDiarmid, E. Black Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation J Urol 189 2013 210